Health Minister Jean-Yves Duclos’ petition to suspend consultations connected guidelines that would little the terms of pharmaceutical drugs has made it harder for the Patented Medicine Prices Review Board to marque decisions going forward, a erstwhile committee subordinate told MPs Tuesday.